We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results

By LabMedica International staff writers
Posted on 26 Jun 2025

Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. More...

These tests are generally known for their high sensitivity and specificity, and they can be developed and adjusted quickly. However, creating standards to confirm that NAATs are operating correctly is much more difficult. Developing reference materials is time-consuming, and appropriate reference measurement procedures (RMPs) have been lacking. A global team of laboratory measurement specialists has now demonstrated that the accuracy of digital PCR can be used to establish an RMP capable of harmonizing results from nucleic acid amplification-based diagnostic tests across laboratories. This method may also offer a solution for performing quality assurance even when physical control materials are unavailable.

The National Measurement Laboratory (NML) at LGC (Middlesex, UK), which serves as the UK's Designated Institute for Chemical and Biological Metrology, has a long-standing reputation for delivering high-accuracy reference methods and materials to ensure the reliability of diagnostic measurements for infectious diseases. In their research, the team employed digital PCR as a reference method to align test outcomes across various labs. This kind of standardization is especially crucial for diagnostic tests used in the absence of clinical criteria—for example, in screening asymptomatic individuals or when immediate clinical decisions are needed and there is no time for confirmatory tests. By leveraging the precision of digital PCR, the international research team led by the NML at LGC has created an RMP that aligns NAAT results. Their findings, published in the journal Clinical Chemistry, offer a path to support quality assurance even before international reference materials are available to ensure traceability.

An editorial in Clinical Chemistry underscored how, during the COVID-19 pandemic, diagnostic labs rapidly developed and deployed NAATs to help control the spread of the virus. Initially, the sensitivity of these tests was unknown, and it was later discovered that performance varied significantly. In the worst cases, tests with low sensitivity produced false-negative results, which, if relied upon, could contribute to the unchecked transmission of the disease. Physical reference materials allow labs to compare NAAT outcomes as part of external quality assurance (EQA) programs. But these materials are slow to produce and cannot be created and distributed at the same speed as the diagnostic tests they are intended to support.

This work examines how RMPs can be used as an additional pathway to support standardization alongside physical reference materials. Unlike the latter, RMPs can be developed and applied as rapidly as new diagnostic tests, which is particularly important for managing infectious diseases. The research aligns with the broader efforts of the NML at LGC and the global metrology community to emphasize the critical role of accurate and timely diagnostics in preparing for future pandemics, recognizing that it is not a question of if another outbreak will occur, but when.

Related Links:
NML at LGC


New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The patented biosensor measures enzymatic activity associated with inflammatory disease (Photo courtesy of Hawkeye Bio)

Non-Invasive and Radiation-Free Diagnostic Identifies Early-Stage Lung Cancer Across All Subtypes

Lung cancer remains the leading cause of cancer-related deaths, with nearly 125,000 deaths and 227,000 new cases estimated in the U.S. for 2025. Despite evidence showing that early detection significantly... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.